| Spinocerebellar ataxia | |
|---|---|
| Classification and external resources | |
Cerebellum (in blue) of the human brain |
|
| ICD-10 | G11 |
| ICD-9 | 334 |
| OMIM | 164400 |
| DiseasesDB | 12339 |
| MeSH | D020754 |
Spinocerebellar ataxia (SCA) is a progressive, degenerative,[1] genetic disease with multiple types, each of which could be considered a disease in its own right.
Contents |
The following is a list of some, not all, types of Spinocerebellar ataxia. The first ataxia gene was identified in 1993 for a dominantly inherited type. It was called “Spinocerebellar ataxia type 1" (SCA1). Subsequently, as additional dominant genes were found they were called SCA2, SCA3, etc. Usually, the "type" number of "SCA" refers to the order in which the gene was found. At this time, there are at least 29 different gene mutations which have been found (not all listed).
Many SCAs below fall under the category of polyglutamine diseases, which are caused when a disease-associated protein (i.e. ataxin-1, ataxin-3, etc.) contains a glutamine repeat beyond a certain threshold. In most dominant polyglutamine diseases, the glutamine repeat threshold is approximately 35, except for SCA3 which is beyond 50. Polyglutamine diseases are also known as "CAG Triplet Repeat Disorders" because CAG is the codon which codes for the amino acid glutamine. Many prefer to refer to these also as polyQ diseases since "Q" is the one-letter reference for glutamine.
| SCA Type | Average Onset (Range in Years) |
Average Duration (Range in Years) |
What the patient experiences | Common origin | Problems with DNA |
|---|---|---|---|---|---|
| SCA1[2] (ATXN1) | 4th decade (<10 to >60) |
15 years (10-35) |
Hypermetric saccades, slow saccades, upper motor neuron (note: saccades relates to eye movement) |
CAG repeat, 6p (Ataxin 1) | |
| SCA2[3] (ATXN2) | 3rd - 4th decade (<10 to >60) |
10 years (1-30) |
Diminished velocity saccades areflexia (absence of neurologic reflexes) |
Cuba | CAG repeat, 12q |
| SCA3[4] (MJD) (ATXN3) | 4th decade (10-70) |
10 years (1-20) |
Also called Machado-Joseph disease (MJD)[5] Gaze-evoked nystagmus (a rapid, involuntary, oscillatory motion of the eyeball) upper motor neuron slow saccades |
Azores (Portugal) |
CAG repeat, 14q |
| SCA4 (PLEKHG4) | 4th - 7th decade (19-72) |
Decades | areflexia (absence of neurologic reflexes) | Chromosome 16q | |
| SCA5 (SPTBN2) | 3rd - 4th decade (10-68) |
>25 years | Pure cerebellar | Chromosome 11 | |
| SCA6[6] (CACNA1A) | 5th - 6th decade (19-71) |
>25 years | Downbeating nystagmus, positional vertigo Symptoms can appear for the first time as late as 65 years old. |
CAG repeat, 19p Calcium channel gene |
|
| SCA7[7] (ATXN7) | 3rd - 4th decade (0.5 - 60) |
20 years (1-45; early onset correlates with shorter duration) |
Macular degeneration, upper motor neuron, slow saccades | CAG repeat, 3p (Ataxin 7) | |
| SCA8[8] (IOSCA) | 39 yrs (18-65) |
Normal lifespan | Horizontal nystagmus (a rapid, involuntary, oscillatory motion of the eyeball), instablility, lack of coordination | CTG repeat[9], 13q | |
| SCA10[10] (ATXN10) | 36 years | 9 years | ataxia, seizures | Mexico | Chromosome 22q linked pentanucleotide repeat |
| SCA11 | 30 yrs (15-70) |
Normal lifespan | Mild, remain ambulatory (able to walk about on one's own) | 15q | |
| SCA12[11] (PPP2R2B) | 33 yrs (8-55) |
Head and hand tremor, akinesia (loss of normal motor function, resulting in impaired muscle movement) |
CAG repeat, 5q | ||
| SCA13 | Childhood or adulthood depending on mutation | Depending on KCNC3 (a kind of gene) | Mental retardation | 19q | |
| SCA14[12] (PRKCG) | 28 yrs (12-42) |
Decades (1-30) |
Myoclonus (a sudden twitching of muscles or parts of muscles, without any rhythm or pattern, occurring in various brain disorders) | 19q | |
| SCA16 | 39 yrs (20-66) |
1–40 years | Head and hand tremor | 8q | |
| SCA17 (TBP) | CAG repeat, 6q (TATA-binding protein) | ||||
| SCA19, SCA22 | Mild cerebellar syndrome, dysarthria | ||||
| SCA25 | 1.5-39 yrs | Unknown | ataxia with sensory neuropathy, vomiting and gastrointestinal pain. | 2p | |
| SCA27[13] | 15-20 yrs | Unknown | ataxia with low cognition, dyskinesias and tremor. | FGF14 13q34 |
Others include SCA18, SCA20, SCA21, SCA23, SCA26, SCA28, and SCA29.
Four X-linked types have been described (302500, 302600, 301790, 301840), but only the first of these has so far been tied to a gene (SCAX1).
Spinocerebellar ataxia (SCA) is one of a group of genetic disorders characterized by slowly progressive incoordination of gait and often associated with poor coordination of hands, speech, and eye movements. Frequently, atrophy of the cerebellum occurs, and different ataxias are known to affect different regions within the cerebellum.[14]
As with other forms of ataxia, SCA results in unsteady and clumsy motion of the body due to a failure of the fine coordination of muscle movements, along with other symptoms.
The symptoms of an ataxia vary with the specific type and with the individual patient. Generally, a person with ataxia retains full mental capacity but may progressively lose physical control.
The hereditary ataxias are categorized by mode of inheritance and causative gene or chromosomal locus. The hereditary ataxias can be inherited in an autosomal dominant, autosomal recessive, or X-linked manner.
There is no currently known cure for spinocerebellar ataxia, which is considered to be a progressive and irreversible disease, although not all types cause equally severe disability. Treatments are generally directed towards alleviating symptoms, not the disease itself. Typically, a person afflicted with this disease will eventually be unable to perform daily tasks.
The treatment of incoordination or ataxia mostly involves the use of adaptive devices to allow the individual to maintain the greatest degree of independence for as long as possible. Such devices may include a cane, crutches, walker, or wheelchair for those with impaired gait. Other devices are available to assist with writing, feeding, and self care if hand and arm coordination are impaired; and communication devices exist to help those with impaired speech. Many patients with hereditary or idiopathic forms of ataxia have other symptoms in addition to ataxia. Medications or other therapies might be appropriate for some of these symptoms, which could include tremor, stiffness, depression, spasticity, and sleep disorders, among others. Both onset of initial symptoms and duration of disease are variable. If the disease is caused by a polyglutamine trinucleotide repeat CAG expansion, a longer expansion may lead to an earlier onset and a more radical progression of clinical symptoms.
| Name | OMIM | RareDiseases | Other |
|---|---|---|---|
| Anemia, sideroblastic spinocerebellar ataxia; Pagon Bird Detter syndrome | 301310 | Disease ID 668 at NIH's Office of Rare Diseases | |
| Friedreich's ataxia; Spinocerebellar ataxia, Friedreich | 229300 | Disease ID 6468 at NIH's Office of Rare Diseases | |
| Infantile onset Spinocerebellar ataxia | 605361 | Disease ID 4062 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 1 | 164400 | Disease ID 4071 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 2 | 183090 | Disease ID 4072 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 3; Machado Joseph disease | 109150 | Disease ID 6801 at NIH's Office of Rare Diseases | machado_joseph/detail_machado_joseph.htm at NINDS |
| Spinocerebellar ataxia 4 | 600223 | Disease ID 9970 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 5 | 600224 | Disease ID 4953 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 7 | 164500 | Disease ID 4955 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 8 | 603680 | Disease ID 4956 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 13 | 605259 | Disease ID 9611 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 18 | 607458 | Disease ID 9976 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 19 | 607346 | Disease ID 9969 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 20 | 608687 | Disease ID 9997 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 21 | 607454 | Disease ID 9999 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 23 | 610245 | Disease ID 9950 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 25 | 608703 | Disease ID 9996 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 26 | 609306 | Disease ID 9995 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 28 | 610246 | Disease ID 9951 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia 30 | 117360 | Disease ID 9975 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia amyotrophy deafness | 271245 | Disease ID 4957 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia, autosomal recessive 1 | 606002 | Disease ID 4949 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia, autosomal recessive 3 | 271250 | Disease ID 9971 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia, autosomal recessive 4 | 607317 | Disease ID 4952 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia, autosomal recessive 5 | 606937 | Disease ID 9977 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia, autosomal recessive 6 | 608029 | Disease ID 4954 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy | 607250 | Disease ID 10000 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia, X-linked, 2 | 302600 | Disease ID 9978 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia, X-linked, 3 | 301790 | Disease ID 9981 at NIH's Office of Rare Diseases | |
| Spinocerebellar ataxia, X-linked, 4 | 301840 | Disease ID 9980 at NIH's Office of Rare Diseases |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||
|
|||||||||||||||||